PaulJuddAndreasonMD

Summary

• Dr. Paul Andreason is a psychiatrist based in Kensington, MD. He has retired from clinical practice and now engages in consulting and expert review. He has 14 years experience with FDA in the Division of Psychiatry Products. He retired from the United States Public Health Service in 2016 after more than 26 years of service. He was heavily involved in domestic disaster response. After retiring from USPHS, he worked for the Midcentral District Health Board in New Zealand as a Senior Consulting Psychiatrist. He completed his residency in psychiatry at the NIH Clinical Center and University of Utah Health after graduating from the University of Utah School of Medicine in 1984. He has contributed to several publications, including research on functional brain imaging using PET, opioid-related trends during the pandemic and the FDA's perspective on antipsychotic medications. His work has been cited numerous times, reflecting his active contribution to the field of psychiatry through academic research.